At Katsuo-ji Temple, Daruma dolls watch from every corner. They peer between tree branches, cluster around altars, and dot winding pathways, flashes of bright red among the hillside forest.

Roche has made its case for BTK inhibitor fenebrutinib as a potential new oral therapy for multiple sclerosis, with a phase 2 readout that it says shows significant improvements in disease ...

BTK killer Dennis Rader has sent him cards and letters, Berkowitz has sent pamphlets about his Son of Hope journey, the Happy Face Killer has mailed dozens of colorful paintings, and Spokane ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...